Flurry of federal and state probes target insulin drugmakers and Pharma middlemen

By Sarah Jane Tribble

With the price of a crucial diabetes drug skyrocketing, at least five states and a federal prosecutor are demanding information from insulin manufacturers and the pharmaceutical industry’s financial middlemen.

Source:: NBC 2 News